Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 11,270

Ridley Scott Associates (RSA), the film production company of famed director Ridley Scott, is launching RSA VR, a new division dedicated to the production of high-end immersive films using VR, AR, and mixed reality. Scott and co. is known for work on acclaimed films such as Alien (1979), Blade Runner (1982), Gladiator (2000), Black Hawk Down (2001), and more throughout his career as a director now going on 40 years.

RSA today announced the launch of RSA VR, a formalization and expansion of RSA’s recent work in VR space which has included the production of The Martian VR Experience (2016) and a forthcoming Alien: Covenant experience.

In a prepared release, the studio calls RSA VR, “a new division dedicated exclusively to the creative development and production of VR, AR and mixed media.”

Read more

Like islands jutting out of a smooth ocean surface, dreams puncture our sleep with disjointed episodes of consciousness. How states of awareness emerge from a sleeping brain has long baffled scientists and philosophers alike.

For decades, scientists have associated dreaming with rapid eye movement (REM) sleep, a sleep stage in which the resting brain paradoxically generates high-frequency brain waves that closely resemble those of when we’re awake.

Yet dreaming isn’t exclusive to REM sleep. A series of oddball reports also found signs of dreaming during non-REM deep sleep, when the brain is dominated by slow-wave activity—the opposite of an alert, active, conscious brain.

Read more

Starving cancer via amino acids looks like a promising approach.

Cutting out certain amino acids — the building blocks of proteins — from the diet of mice slows tumor growth and prolongs survival, according to new research published in Nature.

Researchers at the Cancer Research UK Beatson Institute and the University of Glasgow found that removing two non-essential amino acids — serine and glycine — from the diet of mice slowed the development of lymphoma and intestinal cancer.

The researchers also found that the special diet made some cancer cells more susceptible to chemicals in cells called reactive oxygen species.

Read more

Calling all Longevity Superheroes!

We have launched our Lifespan Heroes campaign to raise funds for LEAF so we can continue delivering quality content, exclusive interviews, scientific commentaries, advocacy and more.

We have made amazing progress over the last two years thanks to our volunteers, but now we need some help from our heroes — the longevity community.

With support from heroes like you we can keep improving Lifespan.io, act on your suggestions, and offer unique rewards to you and the longevity community. Join us!

Read more

Scientists hope they have found a drug to stop all neurodegenerative brain diseases, including dementia. In 2013, a UK Medical Research Council team stopped brain cells dying in an animal for the first time, creating headline news around the world. But the compound used was unsuitable for people, as it caused organ damage. Now two drugs have been found that should have the same protective effect on the brain and are already safely used in people. “It’s really exciting,” said Prof Giovanna Mallucci, from the MRC Toxicology Unit in Leicester. She wants to start human clinical trials on dementia patients soon and expects to know whether the drugs work within two to three years.

Why might they work?

The novel approach is focused on the natural defence mechanisms built into brain cells.

Read more